<DrugInformationSummary id="CDR0000815439"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about nogapendekin alfa inbakicept-pmln
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.
  </DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/nogapendekin-alfa-inbakicept-pmln">Nogapendekin Alfa Inbakicept-pmln</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000751380">nogapendekin alfa inbakicept-pmln</TerminologyLink><GlossaryLink ref="CDR0000815394">nogapendekin alfa inbakicept</GlossaryLink><USBrandNames><USBrandName>Anktiva</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>noh-GAP-en-DEH-kin AL-fuh in-BAK-ih-sept</TermPronunciation><MediaLink ref="CDR0000816251" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000816252" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eae31db8-3e7a-d9e0-708d-74419d1b50ff&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Nogapendekin Alfa Inbakicept-pmln</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eae31db8-3e7a-d9e0-708d-74419d1b50ff&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Nogapendekin
         alfa inbakicept-pmln is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000045122" dictionary="Cancer.gov" audience="Patient">Non-muscle–invasive bladder cancer</GlossaryTermRef></Strong> with <GlossaryTermRef href="CDR0000046488" dictionary="Cancer.gov" audience="Patient">carcinoma in situ</GlossaryTermRef>, with or without <GlossaryTermRef href="CDR0000046240" dictionary="Cancer.gov" audience="Patient">papillary tumors</GlossaryTermRef>. It is used with <GlossaryTermRef href="CDR0000044581" dictionary="Cancer.gov" audience="Patient">bacillus Calmette-Guérin</GlossaryTermRef> (BCG) in adults whose cancer does not respond to treatment with BCG alone.</ListItem>
   
   </ItemizedList>
  <Para id="_4">Nogapendekin
         alfa inbakicept-pmln
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Nogapendekin Alfa Inbakicept-pmln</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751380">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.15">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a624034.html">Nogapendekin
         Alfa Inbakicept-pmln</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.16"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.17">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy">Immunotherapy For Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C205507">Find Clinical Trials for Nogapendekin Alfa Inbakicept-pmln</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2024-05-16</DateFirstPublished><DateLastModified>2024-06-27</DateLastModified></DrugInformationSummary>
